Almac Group Receives Board of Trade Award by the United Kingdom’s Department of International Trade (DIT)

October 25, 2018

Craigavon, N.I., 25 October 2018Almac Group, the global contract development and manufacturing organisation, is pleased to receive the UK’s Board of Trade Award, presented by the UK’s Department of International Trade (DIT) during its “International Trade Day” held aboard the Royal Navy’s HMS Queen Elizabeth in New York.

International Trade Secretary, Dr Liam Fox MP, hosted a series of events on Monday 22nd October aimed at strengthening ties with the US, which took place days after US Treasury Secretary, Robert Lighthizer, announced that the US intends to begin negotiations towards a UK-US Free Trade Agreement after the UK leaves the European Union.

A number of British companies were presented with prestigious Board of Trade Awards by the Secretary of State alongside the Almac Group, recognising their successful export activity. Winners of the Board of Trade Awards come from a broad range of sectors, including life science, space and food & drink, representing the best of British innovation and entrepreneurship.

Mark Weir, US Group Financial Controller, commented: “We are deeply committed to honouring our historic roots by reinvesting in our core asset – our employees – for their work and expertise concentrated in Northern Ireland and internationally. As we celebrate our fiftieth year of business, we wish to thank DIT for continuing to place focus on a strong UK-US partnership, positioning Almac to successfully execute on its mission of ‘partnering to advance human health’.”

According to DIT, trade between the UK and the US totalled more than £180 billion in the year to June 2018, making the US the UK’s largest single nation trading partner and export market. Similarly, Almac reported a 19% rise in revenue in June, marking the first time turnover surpassed £500 million, following continued investment in expansion projects with the building of additional facilities and the construction of one of the largest pharmaceutical cold store facilities in Europe at its Global Headquarters in Craigavon, Northern Ireland.


About Almac Group

A unique culture delivering exceptional solutions

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 5600 highly skilled personnel across 18 facilities including Europe, the US and Asia. Click here to view our facilities.

The company has a global reputation for excellence built over 50 years of client service, delivering expertise right across the drug development lifecycle and offering a tailored solution to each of our clients.

To keep up to date with latest news, follow Almac Group on Twitter and LinkedIn or visit


Back to news